Halozyme(HALO) - 2024 Q4 - Earnings Call Transcript

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Tram Bui - Vice President, Investor Relations & Corporate Communications Helen Torley - President & Chief Executive Officer Nicole LaBrosse - Chief Financial Officer Conference Call Participants Sean Laaman - Morgan Stanley Brendan Smith - TD Cowen Mohit Bansal - Wells Fargo Jessica Fye - JPMorgan Michael DiFiore - Evercore ISI Jason Butler - Citizens JMP Operator Good afternoon. My n ...